These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11108302)
1. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival. González-Barca E; Fernández de Sevilla A; Domingo-Claros A; Romagosa V; Martín-Henao GA; De Sanjose S; Carmona M; Petit J; García J; Grañena A Bone Marrow Transplant; 2000 Nov; 26(10):1051-6. PubMed ID: 11108302 [TBL] [Abstract][Full Text] [Related]
2. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma. Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842 [TBL] [Abstract][Full Text] [Related]
3. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study. Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276 [TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up. Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845 [TBL] [Abstract][Full Text] [Related]
6. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL). Martín-Henao GA; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J Bone Marrow Transplant; 1999 Mar; 23(6):579-87. PubMed ID: 10217189 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells. Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607 [TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission. De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539 [TBL] [Abstract][Full Text] [Related]
9. A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma. Sabloff M; Atkins HL; Bence-Bruckler I; Bredeson C; Fergusson D; Genest P; Hopkins H; Hutton B; Mcdiarmid S; Huebsch LB Biol Blood Marrow Transplant; 2007 Aug; 13(8):956-64. PubMed ID: 17640600 [TBL] [Abstract][Full Text] [Related]
10. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience. López R; Martino R; Sureda A; Nomdedéu J; Briones J; Martin-Henao G; García J; Brunet S; Sierra J Haematologica; 1999 Apr; 84(4):350-5. PubMed ID: 10190950 [TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Pettengell R Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153 [TBL] [Abstract][Full Text] [Related]
13. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study. Yakoub-Agha I; Fawaz A; Folliot O; Guillerm G; Quesnel B; Fenaux P; Bauters F; Jouet JP; Morschhauser F Bone Marrow Transplant; 2002 Aug; 30(4):229-34. PubMed ID: 12203139 [TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106 [TBL] [Abstract][Full Text] [Related]
17. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma. Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma. Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315 [TBL] [Abstract][Full Text] [Related]
19. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction. Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients]. Jin FY; Zou DH; Wang GR; Xu Y; Feng SZ; Zhao YZ; Han MZ; Yan WW; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):645-8. PubMed ID: 16620547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]